G-protein coupled receptor oligomerization in neuroendocrine pathways

Protein-protein interactions are fundamental processes for many biological systems including those involving the superfamily of G-protein coupled receptors (GPCRs). A growing body of biochemical and functional evidence supports the existence of GPCR-GPCR homo- and hetero-oligomers. In particular, hetero-oligomers can display pharmacological and functional properties distinct from those of the homodimer or oligomer thus adding another level of complexity to how GPCRs are activated, signal and traffick in the cell. Dimerization may also play a role in influencing the activity of agonists and antagonists. We are only beginning to unravel how and why such complexes are formed, the functional implications of which will have an enormous impact on GPCR biology. Future research that studies GPCRs as dimeric or oligomeric complexes will enhance not only our understanding of GPCRs in cellular function but will also be critical for novel drug design and improved treatment of the vast array of GPCR-related conditions.

[1]  K. Blumer,et al.  G-protein-coupled receptors function as oligomers in vivo , 2000, Current Biology.

[2]  A. Surprenant,et al.  Dopamine actions on calcium currents, potassium currents and hormone release in rat melanotrophs. , 1991, The Journal of physiology.

[3]  Cristina Limatola,et al.  Ligand-independent CXCR2 Dimerization* , 2003, Journal of Biological Chemistry.

[4]  Lei Shi,et al.  The Fourth Transmembrane Segment Forms the Interface of the Dopamine D2 Receptor Homodimer* , 2003, The Journal of Biological Chemistry.

[5]  L. Potter,et al.  Evidence of paired M2 muscarinic receptors. , 1991, Molecular pharmacology.

[6]  M. Caron,et al.  Phosphorylation and Palmitoylation of the Human D2L Dopamine Receptor in Sf9 Cells , 1994, Journal of neurochemistry.

[7]  Susan R. George,et al.  G-Protein-coupled receptor oligomerization and its potential for drug discovery , 2002, Nature Reviews Drug Discovery.

[8]  Alan Wise,et al.  Heterodimerization is required for the formation of a functional GABAB receptor , 1998, Nature.

[9]  Andrea Kóbor,et al.  Homodimerization of Neuropeptide Y Receptors Investigated by Fluorescence Resonance Energy Transfer in Living Cells* , 2003, The Journal of Biological Chemistry.

[10]  H. Akil,et al.  Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell. , 2000, Molecular pharmacology.

[11]  M. Gershengorn,et al.  Rat TRH receptor type 2 exhibits higher basal signaling activity than TRH receptor type 1. , 1999, Endocrinology.

[12]  T. Gudermann,et al.  Structural Implication for Receptor Oligomerization from Functional Reconstitution Studies of Mutant V2 Vasopressin Receptors* , 2000, The Journal of Biological Chemistry.

[13]  R. Ahn,et al.  Inhibitory activity of alternative splice variants of the bullfrog GnRH receptor-3 on wild-type receptor signaling. , 2001, Endocrinology.

[14]  L. Devi,et al.  G-protein-coupled receptor dimerization: modulation of receptor function. , 2001, Pharmacology & therapeutics.

[15]  Luigi F Agnati,et al.  Molecular Mechanisms and Therapeutical Implications of Intramembrane Receptor/Receptor Interactions among Heptahelical Receptors with Examples from the Striatopallidal GABA Neurons , 2003, Pharmacological Reviews.

[16]  L. Limbird,et al.  Localization of G-protein-coupled receptors in health and disease. , 2000, Trends in pharmacological sciences.

[17]  J. Wess,et al.  Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[18]  B. O'dowd,et al.  TRH-R2 exhibits similar binding and acute signaling but distinct regulation and anatomic distribution compared with TRH-R1. , 2000, Molecular endocrinology.

[19]  H. Lother,et al.  AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration , 2000, Nature.

[20]  G. Demontis,et al.  G protein-linked receptors: pharmacological evidence for the formation of heterodimers. , 1999, The Journal of pharmacology and experimental therapeutics.

[21]  Jayaram Chandrashekar,et al.  An amino-acid taste receptor , 2002, Nature.

[22]  Michel Bouvier,et al.  A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.

[23]  Michele Zoli,et al.  Coaggregation, Cointernalization, and Codesensitization of Adenosine A2A Receptors and Dopamine D2Receptors* , 2002, The Journal of Biological Chemistry.

[24]  B. Kieffer Opioids: first lessons from knockout mice. , 1999, Trends in pharmacological sciences.

[25]  Manuela Pfeiffer,et al.  Heterodimerization of Somatostatin and Opioid Receptors Cross-modulates Phosphorylation, Internalization, and Desensitization* , 2002, The Journal of Biological Chemistry.

[26]  Adam J Pawson,et al.  A novel mammalian receptor for the evolutionarily conserved type II GnRH , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  E. Brown,et al.  Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Nakanishi,et al.  Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor , 2000, Nature.

[29]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[30]  M. Millan,et al.  S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626. , 2000, The Journal of pharmacology and experimental therapeutics.

[31]  C. Martínez-A,et al.  HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. C. Stoof,et al.  Biochemical and physiological studies of the beta-adrenoceptor and the D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland: a review. , 1982, Neuroendocrinology.

[33]  Kendall J Blumer,et al.  The Extracellular N-terminal Domain and Transmembrane Domains 1 and 2 Mediate Oligomerization of a Yeast G Protein-coupled Receptor* , 2002, The Journal of Biological Chemistry.

[34]  B. O'dowd,et al.  Serotonin 5‐HT1B and 5‐HT1D receptors form homodimers when expressed alone and heterodimers when co‐expressed , 1999, FEBS letters.

[35]  B. Barisas,et al.  Luteinizing Hormone Receptors Are Self-Associated in the Plasma Membrane* *This work was supported by NIH Grants HD-23236 and HD-01067 (to D.A.R.). , 2000, Endocrinology.

[36]  E. Lakatta,et al.  'Cross talk' between opioid peptide and adrenergic receptor signaling in isolated rat heart. , 1997, Circulation.

[37]  Michel Bouvier,et al.  Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. , 2002, Annual review of pharmacology and toxicology.

[38]  U. Kumar,et al.  Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. , 2000, Science.

[39]  C. Martínez-A,et al.  The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[40]  H Weinstein,et al.  Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor. , 1997, Endocrine reviews.

[41]  Y. Patel Somatostatin and Its Receptor Family , 1999, Frontiers in Neuroendocrinology.

[42]  B. Mouillac,et al.  Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. , 2003, Molecular endocrinology.

[43]  L. W. Duck,et al.  A gonadotropin-releasing hormone (GnRH) receptor specific for GnRH II in primates. , 2001, Biochemical and biophysical research communications.

[44]  Julie Perroy,et al.  A Single Subunit (GB2) Is Required for G-protein Activation by the Heterodimeric GABAB Receptor* , 2002, The Journal of Biological Chemistry.

[45]  J. Wess,et al.  Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co‐expressed receptor polypeptide. , 1996, The EMBO journal.

[46]  C. Johnson,et al.  A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[47]  L. Devi,et al.  Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[48]  G. Pearlson,et al.  In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder. , 1995, Archives of general psychiatry.

[49]  Pierre Corvol,et al.  Polar Residues in the Transmembrane Domains of the Type 1 Angiotensin II Receptor Are Required for Binding and Coupling , 1996, The Journal of Biological Chemistry.

[50]  Kendall J Blumer,et al.  C5a Receptor Oligomerization , 2003, Journal of Biological Chemistry.

[51]  C. Halldin,et al.  Variability in D2‐dopamine receptor density and affinity: A PET study with [11C]raclopride in man , 1995, Synapse.

[52]  T. Fenton,et al.  Oligomerization of G-protein-coupled Receptors Shown by Selective Co-immunoprecipitation* , 2002, The Journal of Biological Chemistry.

[53]  E I Canela,et al.  Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[54]  F. Piva,et al.  Inhibition of luteinizing hormone-releasing hormone secretion by delta-opioid agonists in GT1-1 neuronal cells. , 1995, Endocrinology.

[55]  B. Barisas,et al.  Binding of agonist but not antagonist leads to fluorescence resonance energy transfer between intrinsically fluorescent gonadotropin-releasing hormone receptors. , 2001, Molecular endocrinology.

[56]  A. Hanyaloglu,et al.  Applications of novel resonance energy transfer techniques to study dynamic hormone receptor interactions in living cells , 2002, Trends in Endocrinology & Metabolism.

[57]  F. Ciruela,et al.  Characterization of the Dimerization of Metabotropic Glutamate Receptors Using an N‐Terminal Truncation of mGluR1α , 1999, Journal of neurochemistry.

[58]  M. Caron,et al.  Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. , 1988, Science.

[59]  S. Nakanishi,et al.  Cryptic dimer interface and domain organization of the extracellular region of metabotropic glutamate receptor subtype 1. , 2000, The Journal of biological chemistry.

[60]  Horst Vogel,et al.  Oligomerization of the α1a- and α1b-Adrenergic Receptor Subtypes , 2003, Journal of Biological Chemistry.

[61]  Jamie Fong,et al.  Regulation of Opioid Receptor Trafficking and Morphine Tolerance by Receptor Oligomerization , 2002, Cell.

[62]  Y. Wang,et al.  A study of protein-protein interactions in living cells using luminescence resonance energy transfer (LRET) from Renilla luciferase to Aequorea GFP , 2001, Molecular and General Genetics MGG.

[63]  Yoshinori Shichida,et al.  Functional role of internal water molecules in rhodopsin revealed by x-ray crystallography , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[64]  T. Kohout,et al.  Homo- and Hetero-oligomerization of Thyrotropin-releasing Hormone (TRH) Receptor Subtypes , 2002, The Journal of Biological Chemistry.

[65]  A. Cornea,et al.  Gonadotropin-releasing Hormone Receptor Microaggregation , 2001, The Journal of Biological Chemistry.

[66]  D. A. Brown,et al.  GABAB2 Is Essential for G-Protein Coupling of the GABAB Receptor Heterodimer , 2001, The Journal of Neuroscience.

[67]  S. Schulz,et al.  Homo- and Heterodimerization of Somatostatin Receptor Subtypes , 2001, The Journal of Biological Chemistry.

[68]  F. Petraglia,et al.  Opioid control of luteinizing hormone secretion in humans. , 1989, Journal of steroid biochemistry.

[69]  R. Crystal,et al.  Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions. , 2002, Human gene therapy.

[70]  J. Venter,et al.  Molecular size of the canine and human brain D2 dopamine receptor as determined by radiation inactivation. , 1983, Molecular pharmacology.

[71]  Lakshmi A. Devi,et al.  Heterodimerization of μ and δ Opioid Receptors: A Role in Opiate Synergy , 2000, The Journal of Neuroscience.

[72]  B. O'dowd,et al.  Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. , 2000, The Journal of biological chemistry.

[73]  M. Memo,et al.  Dopaminergic Inhibition of Prolactin Release and Calcium Influx Induced by Neurotensin in Anterior Pituitary Is Independent of Cyclic AMP System , 1986, Journal of neurochemistry.

[74]  H. Jinnah,et al.  Regulation of gonadotropin release, GnRH receptors, and gonadotrope responsiveness: A role for GnRH receptor microaggregation , 1985, Journal of cellular biochemistry.

[75]  S. Jiang,et al.  Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells. , 1997, Cancer research.

[76]  R. Lefkowitz,et al.  Negative cooperativity among beta-adrenergic receptors in frog erythrocyte membranes. , 1976, The Journal of biological chemistry.

[77]  C. Gerfen,et al.  A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[78]  Y. Jan,et al.  A Trafficking Checkpoint Controls GABAB Receptor Heterodimerization , 2000, Neuron.

[79]  P. Conn,et al.  Biphasic regulation of the gonadotropin-releasing hormone receptor by receptor microaggregation and intracellular Ca2+ levels. , 1984, Molecular pharmacology.

[80]  P. Fossier,et al.  Monitoring of Ligand-independent Dimerization and Ligand-induced Conformational Changes of Melatonin Receptors in Living Cells by Bioluminescence Resonance Energy Transfer* 210 , 2002, The Journal of Biological Chemistry.

[81]  K. Fuxe,et al.  Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: Implications for striatal neuronal function , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[82]  S. Rees,et al.  Monitoring Receptor Oligomerization Using Time-resolved Fluorescence Resonance Energy Transfer and Bioluminescence Resonance Energy Transfer , 2001, The Journal of Biological Chemistry.

[83]  H. Lother,et al.  Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness , 2001, Nature Medicine.

[84]  R. Bílek TRH-like peptides in prostate gland and other tissues. , 2000, Physiological research.

[85]  S. R. Nash,et al.  Dopamine receptors: from structure to function. , 1998, Physiological reviews.

[86]  L. Devi,et al.  Oligomerization of opioid receptors. , 2002, Methods.

[87]  T. Wong,et al.  Cross-talk Between Cardiacκ-Opioid andβ-Adrenergic Receptors in Developing Hypertensive Rats , 1999 .

[88]  W. A. Smith,et al.  Microaggregation of the gonadotropin-releasing hormone-receptor: relation to gonadotrope desensitization. , 1984, Endocrinology.

[89]  R. Millar GnRH II and type II GnRH receptors , 2003, Trends in Endocrinology & Metabolism.

[90]  Gilles Labesse,et al.  No Ligand Binding in the GB2 Subunit of the GABABReceptor Is Required for Activation and Allosteric Interaction between the Subunits , 2002, The Journal of Neuroscience.

[91]  Mario Mellado,et al.  Chemokine receptor homo‐ or heterodimerization activates distinct signaling pathways , 2001, The EMBO journal.

[92]  U. Kumar,et al.  Expression of the Five Somatostatin Receptor (SSTR1-5) Subtypes in Rat Pituitary Somatotrophes: Quantitative Analysis by Double-Label Immunofluorescence Confocal Microscopy. , 1997, Endocrinology.

[93]  A. Horita,et al.  An update on the CNS actions of TRH and its analogs. , 1998, Life sciences.

[94]  H. Lother,et al.  The Angiotensin II AT2 Receptor Is an AT1Receptor Antagonist* , 2001, The Journal of Biological Chemistry.

[95]  S. Nakanishi,et al.  Amino Acid Mutagenesis of the Ligand Binding Site and the Dimer Interface of the Metabotropic Glutamate Receptor 1 , 2003, The Journal of Biological Chemistry.

[96]  Kuan-Teh Jeang,et al.  Mechanism of Transdominant Inhibition of CCR5-mediated HIV-1 Infection by ccr5Δ32* , 1997, The Journal of Biological Chemistry.

[97]  M. Gershengorn,et al.  Thyrotropin-releasing hormone receptors -- similarities and differences. , 2003, Journal of molecular endocrinology.

[98]  H. Nakata,et al.  Agonist‐promoted heteromeric oligomerization between adenosine A1 and P2Y1 receptors in living cells , 2002, FEBS letters.

[99]  A. Norman,et al.  Heptahelical receptor superfamily , 2003 .

[100]  S. Schulz,et al.  Selective targeting of somatostatin receptor 3 to neuronal cilia , 1999, Neuroscience.

[101]  H. Iwaasa,et al.  Cloning and characterization of a new subtype of thyrotropin-releasing hormone receptors. , 1998, Biochemical and biophysical research communications.

[102]  G. Milligan,et al.  Oligomerisation of G-protein-coupled receptors. , 2001, Journal of cell science.

[103]  E. Hazum,et al.  Gonadotropin releasing hormone activation is mediated by dimerization of occupied receptors. , 1985, Biochemical and biophysical research communications.

[104]  S. Wilt,et al.  Heterodimerization of Calcium Sensing Receptors with Metabotropic Glutamate Receptors in Neurons* , 2001, The Journal of Biological Chemistry.

[105]  K. Davis,et al.  Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[106]  E. Brown,et al.  The Extracellular Calcium-sensing Receptor Dimerizes through Multiple Types of Intermolecular Interactions* , 2001, The Journal of Biological Chemistry.

[107]  L. Devi,et al.  Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.

[108]  J. Wess,et al.  Reconstitution of functional muscarinic receptors by co‐expression of amino‐ and carboxyl‐terminal receptor fragments , 1993, FEBS letters.

[109]  Krzysztof Palczewski,et al.  Organization of the G Protein-coupled Receptors Rhodopsin and Opsin in Native Membranes* , 2003, Journal of Biological Chemistry.

[110]  E. Lakatta,et al.  β1/β2-Adrenergic Receptor Heterodimerization Regulates β2-Adrenergic Receptor Internalization and ERK Signaling Efficacy* , 2002, The Journal of Biological Chemistry.

[111]  K Payza,et al.  Cloning and Characterization of a cDNA Encoding a Novel Subtype of Rat Thyrotropin-releasing Hormone Receptor* , 1998, The Journal of Biological Chemistry.

[112]  T. Gudermann,et al.  Inhibition of gonadotropin-releasing hormone receptor signaling by expression of a splice variant of the human receptor. , 1997, Molecular endocrinology.

[113]  Lakshmi A. Devi,et al.  G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.

[114]  U. Kumar,et al.  Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers* , 2000, The Journal of Biological Chemistry.

[115]  L. Miller,et al.  Agonist-dependent Dissociation of Oligomeric Complexes of G Protein-coupled Cholecystokinin Receptors Demonstrated in Living Cells Using Bioluminescence Resonance Energy Transfer* , 2001, The Journal of Biological Chemistry.

[116]  J Engel,et al.  Heterodimerization of a functional GABAB receptor is mediated by parallel coiled-coil alpha-helices. , 1999, Biochemistry.

[117]  A. Norman,et al.  Encyclopedia of hormones , 2003 .

[118]  P. Seeman,et al.  Dopamine D2 receptor dimers in human and rat brain , 1998, FEBS letters.

[119]  A. Lau,et al.  Heterodimerization of α2A- and β1-Adrenergic Receptors* , 2003, The Journal of Biological Chemistry.

[120]  Paul D. Scott,et al.  Dimerization of G-protein-coupled receptors. , 2001 .

[121]  J. Janovick,et al.  Gonadotropin releasing hormone agonist provokes homologous receptor microaggregation: an early event in seven-transmembrane receptor mediated signaling. , 1996, Endocrinology.

[122]  Ramesh C. Patel,et al.  Photobleaching fluorescence resonance energy transfer reveals ligand-induced oligomer formation of human somatostatin receptor subtypes. , 2002, Methods.

[123]  Roger Y Tsien,et al.  Recent advances in technology for measuring and manipulating cell signals , 2000, Current Opinion in Neurobiology.

[124]  M. Entman,et al.  Guanine nucleotide regulation of a mammalian myocardial muscarinic receptor system. Evidence for homo- and heterotropic cooperativity in ligand binding analyzed by computer-assisted curve fitting. , 1985, The Journal of biological chemistry.

[125]  M. Gershengorn,et al.  Regulator of G Protein Signaling 4 Suppresses Basal and Thyrotropin Releasing-Hormone (TRH)-Stimulated Signaling by Two Mouse TRH Receptors, TRH-R1 and TRH-R2. , 2001, Endocrinology.

[126]  R. Shigemoto,et al.  GABAB-receptor subtypes assemble into functional heteromeric complexes , 1998, Nature.

[127]  J. Wess,et al.  Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implication. , 1997, The Journal of clinical investigation.

[128]  A. Arai,et al.  The carboxyl terminus of the prolactin-releasing peptide receptor interacts with PDZ domain proteins involved in alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor clustering. , 2001, Molecular pharmacology.

[129]  L. Prézeau,et al.  C-Terminal Interaction Is Essential for Surface Trafficking But Not for Heteromeric Assembly of GABAB Receptors , 2001, The Journal of Neuroscience.

[130]  F. Ciruela,et al.  Metabotropic Glutamate 1α and Adenosine A1 Receptors Assemble into Functionally Interacting Complexes* , 2001, The Journal of Biological Chemistry.

[131]  Michel Bouvier,et al.  Oligomerization of G-protein-coupled transmitter receptors , 2001, Nature Reviews Neuroscience.

[132]  Graeme Milligan,et al.  Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. , 2002, The Biochemical journal.

[133]  A. Engel,et al.  Atomic-force microscopy: Rhodopsin dimers in native disc membranes , 2003, Nature.

[134]  D. Wong,et al.  In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428 , 1993, Synapse.

[135]  J. Stewart,et al.  Conversion of a gonadotropin-releasing hormone antagonist to an agonist , 1982, Nature.

[136]  R. Latif,et al.  Ligand-dependent Inhibition of Oligomerization at the Human Thyrotropin Receptor* , 2002, The Journal of Biological Chemistry.

[137]  D C Teller,et al.  Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). , 2001, Biochemistry.

[138]  Alan A. Wilson,et al.  Dopamine D2 receptor density estimates in schizophrenia: A positron emission tomography study with11C-N-methylspiperone , 1993, Psychiatry Research.

[139]  P. Seeman,et al.  A Transmembrane Domain-derived Peptide Inhibits D1 Dopamine Receptor Function without Affecting Receptor Oligomerization* , 1998, The Journal of Biological Chemistry.

[140]  Adam J Pawson,et al.  A transcriptionally active human type II gonadotropin-releasing hormone receptor gene homolog overlaps two genes in the antisense orientation on chromosome 1q.12. , 2003, Endocrinology.

[141]  M. Bouvier,et al.  Functional rescue of a constitutively desensitized beta2AR through receptor dimerization. , 1998, The Biochemical journal.

[142]  Lakshmi A Devi,et al.  Opioids and Their Complicated Receptor Complexes , 2000, Neuropsychopharmacology.

[143]  S. Ferré,et al.  Adenosine as a volume transmission signal. A feedback detector of neuronal activation. , 2000, Progress in brain research.

[144]  K. Ray,et al.  Cys-140 Is Critical for Metabotropic Glutamate Receptor-1 Dimerization* , 2000, The Journal of Biological Chemistry.

[145]  Kenneth A. Jones,et al.  GABAB receptors function as a heteromeric assembly of the subunits GABABR1 and GABABR2 , 1998, Nature.

[146]  S. Schulz,et al.  Immunocytochemical localization of somatostatin receptor sst2A in the rat spinal cord and dorsal root ganglia , 1998, The European journal of neuroscience.

[147]  C. Bergson,et al.  On the origin of mRNA encoding the truncated dopamine D3-type receptor D3nf and detection of D3nf-like immunoreactivity in human brain. , 1994, The Journal of biological chemistry.

[148]  L. Prézeau,et al.  Mapping the Agonist-binding Site of GABAB Type 1 Subunit Sheds Light on the Activation Process of GABABReceptors* , 2000, The Journal of Biological Chemistry.

[149]  Y. Kuroda,et al.  Hetero‐oligomerization of adenosine A1 receptors with P2Y1 receptors in rat brains , 2002, FEBS letters.

[150]  Enrico Gratton,et al.  Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[151]  J. Morrison,et al.  Expression of Dopamine D3 Receptor Dimers and Tetramers in Brain and in Transfected Cells* , 1997, The Journal of Biological Chemistry.

[152]  Lakshmi A. Devi,et al.  G protein coupled receptor dimerization: implications in modulating receptor function , 2001, Journal of Molecular Medicine.

[153]  H. Lother,et al.  Involvement of the Amino Terminus of the B2 Receptor in Agonist-induced Receptor Dimerization* , 1999, The Journal of Biological Chemistry.

[154]  S. Stone-Elander,et al.  D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride. , 1990, Archives of general psychiatry.

[155]  Michel Bouvier,et al.  Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). , 2000 .

[156]  Chang-Cheng Zhu,et al.  Dimerization and Phosphorylation of Thyrotropin-releasing Hormone Receptors Are Modulated by Agonist Stimulation* , 2002, The Journal of Biological Chemistry.

[157]  J. Bockaert,et al.  Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary. , 1983, Molecular pharmacology.

[158]  J. Venter,et al.  Molecular size of the human platelet alpha 2-adrenergic receptor as determined by radiation inactivation. , 1983, Biochemical and biophysical research communications.

[159]  G. Corsini,et al.  Functional Role of the Third Cytoplasmic Loop in Muscarinic Receptor Dimerization* , 1996, The Journal of Biological Chemistry.

[160]  Michel Bouvier,et al.  Constitutive Agonist-independent CCR5 Oligomerization and Antibody-mediated Clustering Occurring at Physiological Levels of Receptors* 210 , 2002, The Journal of Biological Chemistry.

[161]  J. Wess,et al.  Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. , 1998, Biochemistry.

[162]  T. Yaksh New horizons in our understanding of the spinal physiology and pharmacology of pain processing. , 1993, Seminars in oncology.

[163]  Jie Liu,et al.  Plasma Membrane Localization and Functional Rescue of Truncated Forms of a G Protein-coupled Receptor (*) , 1995, The Journal of Biological Chemistry.

[164]  R Levenson,et al.  The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors. , 2000, Molecular pharmacology.

[165]  P. Seeman,et al.  Resistance of the dopamine D2L receptor to desensitization accompanies the up-regulation of receptors on to the surface of Sf9 cells. , 1997, Endocrinology.

[166]  A. Hanyaloglu,et al.  Constitutive and Agonist-dependent Homo-oligomerization of the Thyrotropin-releasing Hormone Receptor , 2001, The Journal of Biological Chemistry.

[167]  S. Nakagawa,et al.  The metabolic rate and vulnerability of dopaminergic neurons, and adenosine dynamics in the cerebral cortex, nucleus accumbens, caudate nucleus, and putamen of the common marmoset , 2000, Journal of Neurology.

[168]  P. Seeman,et al.  Dopamine D2 receptor dimers and receptor-blocking peptides. , 1996, Biochemical and biophysical research communications.

[169]  Hans Bräuner-Osborne,et al.  Probing intermolecular protein-protein interactions in the calcium-sensing receptor homodimer using bioluminescence resonance energy transfer (BRET). , 2002, European journal of biochemistry.

[170]  C. Romano,et al.  Metabotropic Glutamate Receptor 5 Is a Disulfide-linked Dimer* , 1996, The Journal of Biological Chemistry.

[171]  N. Ben-Jonathan Dopamine: a prolactin-inhibiting hormone. , 1985, Endocrine reviews.

[172]  E. Brown,et al.  Dimerization of the Extracellular Calcium-sensing Receptor (CaR) on the Cell Surface of CaR-transfected HEK293 Cells* , 1998, The Journal of Biological Chemistry.

[173]  H. Nakata,et al.  Heteromeric association creates a P2Y-like adenosine receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[174]  Gregory J Babcock,et al.  Ligand-independent Dimerization of CXCR4, a Principal HIV-1 Coreceptor* , 2003, The Journal of Biological Chemistry.

[175]  Christer Halldin,et al.  No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone , 1995, Psychiatry Research: Neuroimaging.

[176]  L. Miller,et al.  Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma. , 2002, Cancer research.

[177]  J. Wess,et al.  Identification and Molecular Characterization of m3 Muscarinic Receptor Dimers* , 1999, The Journal of Biological Chemistry.

[178]  B. O'dowd,et al.  The splice variant D3nf reduces ligand binding to the D3 dopamine receptor: evidence for heterooligomerization. , 2000, Brain research. Molecular brain research.

[179]  P. Cuatrecasas,et al.  Increased biological activity of dimers of oxymorphone and enkephalin: possible role of receptor crosslinking. , 1982, Biochemical and biophysical research communications.

[180]  H. Nakata,et al.  Oligomerization of adenosine A2A and dopamine D2 receptors in living cells. , 2003, Biochemical and biophysical research communications.

[181]  P. Sokoloff,et al.  D2/D3 Dopamine Receptor Heterodimers Exhibit Unique Functional Properties* , 2001, The Journal of Biological Chemistry.

[182]  R. Russell,et al.  The C-Terminal Domains of the GABAB Receptor Subunits Mediate Intracellular Trafficking But Are Not Required for Receptor Signaling , 2001, The Journal of Neuroscience.

[183]  Jean-François Mercier,et al.  Quantitative Assessment of β1- and β2-Adrenergic Receptor Homo- and Heterodimerization by Bioluminescence Resonance Energy Transfer* , 2002, The Journal of Biological Chemistry.

[184]  K. Roche,et al.  Homer 1b Regulates the Trafficking of Group I Metabotropic Glutamate Receptors* , 1999, The Journal of Biological Chemistry.

[185]  C Higgs,et al.  Domain swapping in G-protein coupled receptor dimers. , 1998, Protein engineering.

[186]  Christopher A Reynolds,et al.  Dimerization and Domain Swapping in G-Protein-Coupled Receptors: A Computational Study , 2000, Neuropsychopharmacology.

[187]  P. Pauwels,et al.  Agonist‐independent and ‐dependent oligomerization of dopamine D2 receptors by fusion to fluorescent proteins , 2001, FEBS letters.